• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Editorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives.

作者信息

Zhavoronkov Alex, Moskalev Alexey

机构信息

The Biogerontology Research FoundationOxford, UK; Insilico Medicine Inc.Baltimore, MD, USA; Laboratory of Regenerative Medicine, Federal Research and Clinical Centre of Pediatric Hematology, Oncology and ImmunologyMoscow, Russia.

Insilico Medicine Inc.Baltimore, MD, USA; Radiation Ecology, Laboratory of Molecular Radiobiology and Gerontology, Institute of Biology of Komi Science Center of Ural Branch of RASSyktyvkar, Russia; Biological and Medical Physics Department, Moscow Institute of Physics and Technology (State University)Dolgoprudny, Russia.

出版信息

Front Genet. 2016 Feb 16;7:17. doi: 10.3389/fgene.2016.00017. eCollection 2016.

DOI:10.3389/fgene.2016.00017
PMID:26909101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4754422/
Abstract
摘要

相似文献

1
Editorial: Should We Treat Aging as a Disease? Academic, Pharmaceutical, Healthcare Policy, and Pension Fund Perspectives.社论：我们应该将衰老视为一种疾病吗？学术、制药、医疗保健政策及养老基金视角。
Front Genet. 2016 Feb 16;7:17. doi: 10.3389/fgene.2016.00017. eCollection 2016.
2
Stop Aging Disease! ICAD 2014.抗击衰老疾病！2014年国际抗衰老大会
Aging Dis. 2015 Mar 10;6(2):76-94. doi: 10.14336/AD.2015.0115. eCollection 2015 Mar.
3
Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives.在公共卫生实践中推广延寿补充剂和药物的实施：成就、挑战和未来展望。
J Transl Med. 2017 Jul 20;15(1):160. doi: 10.1186/s12967-017-1259-8.
4
Australian pension funds and tobacco investments: promoting ill health and out-of-step with their members.澳大利亚养老基金与烟草投资：助长健康问题且与成员意愿相悖。
Health Promot Int. 2008 Mar;23(1):35-41. doi: 10.1093/heapro/dam043. Epub 2007 Dec 19.
5
Life span extension and cancer risk: myths and reality.寿命延长与癌症风险：误区与真相
Exp Gerontol. 2001 Jul;36(7):1101-36. doi: 10.1016/s0531-5565(01)00114-0.
6
Artificial intelligence for aging and longevity research: Recent advances and perspectives.人工智能在衰老和长寿研究中的应用：最新进展与展望。
Ageing Res Rev. 2019 Jan;49:49-66. doi: 10.1016/j.arr.2018.11.003. Epub 2018 Nov 22.
7
In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state.寻找老年保护剂：年轻健康状态信号组水平模拟物的计算机模拟筛选和体外验证
Aging (Albany NY). 2016 Sep 24;8(9):2127-2152. doi: 10.18632/aging.101047.
8
Biogerontology in Italy.意大利的生物老年学。
Biogerontology. 2011 Feb;12(1):61-9. doi: 10.1007/s10522-010-9312-5. Epub 2010 Dec 12.
9
[Geroprotectors: specific action or hormesis?].[老年保护剂：特定作用还是应激效应？]
Adv Gerontol. 2008;21(4):564-9.
10
Research on the Accumulation Effect of Pension Income and Payments Caused by Progressive Retirement Age Postponement Policy in China.中国渐进式延迟退休年龄政策对养老金收支积累效应的研究。
J Aging Soc Policy. 2019 Mar-Apr;31(2):155-169. doi: 10.1080/08959420.2018.1500859. Epub 2018 Oct 25.

引用本文的文献

1
Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections.减少嗜老年菌和嗜老年病毒感染中的合并症、感染率、严重程度及致死率的老年保护和衰老修复策略。
Aging (Albany NY). 2020 Mar 31;12(8):6492-6510. doi: 10.18632/aging.102988.
2
Polygenic risk score for disability and insights into disability-related molecular mechanisms.多基因风险评分与残疾及残疾相关分子机制的见解。
Geroscience. 2019 Dec;41(6):881-893. doi: 10.1007/s11357-019-00125-8. Epub 2019 Nov 9.
3
Strong impact of natural-selection-free heterogeneity in genetics of age-related phenotypes.自然选择无关的异质性对年龄相关表型遗传学有强烈影响。
Aging (Albany NY). 2018 Mar 29;10(3):492-514. doi: 10.18632/aging.101407.
4
Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives.在公共卫生实践中推广延寿补充剂和药物的实施：成就、挑战和未来展望。
J Transl Med. 2017 Jul 20;15(1):160. doi: 10.1186/s12967-017-1259-8.
5
Geroprotectors: A Unified Concept and Screening Approaches.老年保护剂：统一概念与筛选方法
Aging Dis. 2017 May 2;8(3):354-363. doi: 10.14336/AD.2016.1022. eCollection 2017 May.
6
Classifying Aging As a Disease: The Role of Microbes.将衰老归类为一种疾病：微生物的作用。
Front Genet. 2016 Dec 1;7:212. doi: 10.3389/fgene.2016.00212. eCollection 2016.
7
Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality.2q22区域等位基因变异与主要人类疾病风险和死亡率的多效性关联。
PLoS Genet. 2016 Nov 10;12(11):e1006314. doi: 10.1371/journal.pgen.1006314. eCollection 2016 Nov.
8
In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state.寻找老年保护剂：年轻健康状态信号组水平模拟物的计算机模拟筛选和体外验证
Aging (Albany NY). 2016 Sep 24;8(9):2127-2152. doi: 10.18632/aging.101047.

本文引用的文献

1
Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease.Geroprotectors.org：一个关于衰老及与年龄相关疾病的当前治疗干预措施的全新、结构化且经过筛选的数据库。
Aging (Albany NY). 2015 Sep;7(9):616-28. doi: 10.18632/aging.100799.
2
Longevity expectations in the pension fund, insurance, and employee benefits industries.养老金、保险和员工福利行业的寿命预期。
Psychol Res Behav Manag. 2015 Jan 20;8:27-39. doi: 10.2147/PRBM.S75440. eCollection 2015.
3
Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells.衰老过程中的信号通路激活漂移：哈钦森-吉尔福德早衰综合征成纤维细胞与正常中年和老年细胞具有可比性。
Aging (Albany NY). 2015 Jan;7(1):26-37. doi: 10.18632/aging.100717.
4
Pathway activation profiling reveals new insights into age-related macular degeneration and provides avenues for therapeutic interventions.通路激活分析揭示了与年龄相关性黄斑变性的新见解，并为治疗干预提供了途径。
Aging (Albany NY). 2014 Dec;6(12):1064-75. doi: 10.18632/aging.100711.
5
Genetics and epigenetics of aging and longevity.衰老与长寿的遗传学和表观遗传学
Cell Cycle. 2014;13(7):1063-77. doi: 10.4161/cc.28433. Epub 2014 Mar 6.
6
Biomedical progress rates as new parameters for models of economic growth in developed countries.生物医学进步率作为发达国家经济增长模型的新参数。
Int J Environ Res Public Health. 2013 Nov 8;10(11):5936-52. doi: 10.3390/ijerph10115936.
7
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率：全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
8
Molecular links between cellular senescence, longevity and age-related diseases - a systems biology perspective.细胞衰老、长寿与年龄相关疾病之间的分子联系——系统生物学视角
Aging (Albany NY). 2011 Dec;3(12):1178-91. doi: 10.18632/aging.100413.
9
Methods for structuring scientific knowledge from many areas related to aging research.从与衰老研究相关的多个领域构建科学知识的方法。
PLoS One. 2011;6(7):e22597. doi: 10.1371/journal.pone.0022597. Epub 2011 Jul 22.